[1]
Gurevičienė, G. 2024. THE PHARMACOKINETICS, EFFICACY, IMMUNOGENICITY, AND SAFETY OF ATEZOLIZUMAB SUBCUTANEOUS IN NON-SMALL-CELL LUNG CANCER. IMSCIN001 CLINICAL STUDY (PART 2). Pulmonology and allergology. 8, 2 (Sep. 2024), 214-218. DOI:https://doi.org/10.37499/PIA.1492.